This major conference brings together more than 3,000 academics, scientists and representatives from the pharmaceutical industry to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomized, multicenter cancer clinical trials. Together, the level of excitement surrounding targeted therapy and the high caliber of the science presented fuel the power of this meeting to attract the world’s leaders in the development of new cancer therapeutics.
Listen to these press conferences and video podcast interviews of selected speakers from this meeting.
Molecular Targets and Cancer Therapeutics 2011: New Research in Breast Cancer Teleconference
Kenneth C. Anderson, M.D., Kraft Family professor of medicine and program director and chief of the division of hematologic neoplasia at Dana-Farber Cancer Institute and Harvard Medical School hosted this teleconference with the media Sunday, Nov. 13, 2011, at 7:30 a.m. PT.
Molecular Targets and Cancer Therapeutics 2011: Teleconference on Progress in Angiogenesis
James H. Doroshow, M.D., FACP, deputy director for clinical and translational research at the National Cancer Institute, hosted this press conference Sunday, Nov. 13, 2011, at 11:00a.m. PT.
Interview with José Baselga, M.D., Ph.D., associate director, chief of hematology/oncology, Massachusetts General Hospital Cancer Center
Interview with René Bernards, Ph.D., division head, molecular carcinogenesis, The Netherlands Cancer Institute
Interview with Robert Brown, Ph.D., chair, translational oncology, Imperial College London
Interview with Christian Dittrich, M.D., professor of medicine, Kaiser Franz Josef-Spital, Vienna, Austria
Interview with James H. Doroshow, M.D., FACP, deputy director for Clinical and Translational Research, National Cancer Institute
Interview with William C. Hahn, M.D., Ph.D., director, Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School
Interview with William N. Hait, M.D., Ph.D., global therapeutic area head of oncology, Johnson & Johnson Pharmaceuticals Research and Development, L.L.C.
Interview with Nadia Harbeck, M.D., Ph.D., head, Interdisciplinary Breast Center, University Hospital of Cologne
Interview with William Pao, M.D., Ph.D., Ingram associate professor of cancer research; director, division of hematology and oncology and personalized cancer medicine, Vanderbilt-Ingram Cancer Center
Interview with Daniel R. Rhodes, Ph.D., chief executive officer, Compendia Bioscience
Interview with Cynthia A. Zahnow, Ph.D., assistant professor of oncology, Johns Hopkins University
Check back frequently to stay up-to-date or subscribe to the AACR Scientific Podcasts feed through the following:
Subscribe to the AACR Scientific Podcasts via an RSS Reader.
Follow AACR on Twitter @AACR.
Subscribe to the AACR RSS News Feed
Download the AACR Video App for the iPhone, iPad and Android Devices
Updated: Nov. 15, 2011